Advertisement
AD

Main navigation

Bitcoin Price Should Continue to Rise, Bloomberg's Mike McGlone Says

Advertisement
Wed, 19/10/2022 - 19:16
Bitcoin Price Should Continue to Rise, Bloomberg's Mike McGlone Says
Cover image via stock.adobe.com
Read U.TODAY on
Google News

In a recent tweet, Mike McGlone, chief commodity strategist at Bloomberg Intelligence, claims that the Bitcoin price should continue to rise over time without providing a specific timeframe.

Advertisement

McGlone calls Bitcoin’s definable diminishing supply “unprecedented” on a global scale simply due to the laws of supply and demand.

He notes the lack of supply elasticity is the main factor that differentiates Bitcoin from other popular commodities.   

However, the analyst doesn’t rule out that a black swan event could throw a wrench in the works for bulls. In such a case, demand and adoption trends would be reversed, but such a scenario is “unlikely,” according to the analyst.

Related
Cardano (ADA) May Fade into Obscurity Like EOS, Top Trader Claims

It should be mentioned that McGlone’s price calls should be taken with a grain of salt after some unsuccessful predictions. In September 2021, he was still claiming that the largest cryptocurrency was on track to hit the $100,000 level. However, the crypto king peaked at $69,000 before retracing significantly lower by the end of the year.

However, the Bloomberg analyst continues to stand by his bullish prediction. As reported by U.Today, McGlone said that Bitcoin reaching five-digit territory was only “a matter of time” in early September.

The largest cryptocurrency has been range-bound for months, with its volatility recently reaching the lowest level of the year.

At press time, the largest cryptocurrency is sitting at $19,182 on the Bitstamp exchange after declining roughly 0.20% over the last 24 hours.  

Advertisement
TopCryptoNewsinYourMailbox
TopCryptoNewsinYourMailbox
Advertisement

Latest Press Releases

Our social media
There's a lot to see there, too

Popular articles

Advertisement
AD